Exposure-response analysis as evidence for anti-tumor activity of everolimus in the treatment of patients with subependymal giant-cell astrocytoma (SEGA) associated with tuberous sclerosis (TS).

N Mehrotra,E Pfuma,A H Shahlaee,B Booth,C Garnett,K Liu,N A Rahman,Q Liu

doi:10.1200/jco.2011.29.15_suppl.9550

Exposure-response analysis as evidence for anti-tumor activity of everolimus in the treatment of patients with subependymal giant-cell astrocytoma (SEGA) associated with tuberous sclerosis (TS).

N Mehrotra, E Pfuma + Show 6 more

https://doi.org/10.1200/jco.2011.29.15_suppl.9550

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2011
Citations: 1

#Subependymal Giant-cell Astrocytoma #Tuberous Sclerosis + Show 6 more

Abstract
Full-Text PDF
Similar Papers

Abstract

9550 Background: On October 29, 2010 the US FDA granted accelerated approval for the use of everolimus in the treatment of patients with SEGA associated with TS not amenable to curative surgical re...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.